韓茵蔯, 鬱金, 山査, 丹蔘 발효복합추출물이 RAW264.7 및 HUVEC 세포에서 나타나는 이상지질혈증 관련 염증인자 발현 및 항산화에 미치는 영향
The Effects of an Extract of Fermented Artemisiae Iwayomogii Herba, Curcumae Longae, Crataegi Fructus and Salviae Miltiorrhizae Radix on Anti-inflammation Associated with Dyslipidemia and Anti-oxidation in RAW264.7 and HUVEC Cells
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Objectives: To investigate the effect of fermented extract of Artemisiae Iwayomogii Herba, Curcumae Longae, Crataegi Fructus, and Salviae Miltiorrhizae Radix (FMH) on anti-inflammation associated with dyslipidemia and anti-oxidation in RAW264.7 and HUVEC cells. Methods: The total polyphenols, total flavonoids, DPPH radical scavenging activity, ABTS radical scavenging activity, and cytotoxicity of FMH were measured. RAW264.7 cells treated with FMH were tested for production of NO, and for cytokine and LTB4 levels and HUVEC cells treated with FMH were examined for production of cDNA of genes related to inflammation. Results: 1. FMH contained polyphenols and flavonoids. The DPPH and ABTS radical scavenging activity of FMH increased in a concentration-dependent manner. 2. FMH treatment inhibited the production of nitric oxide (NO), cytokines, and LTB4 in RAW264.7 cell when compared to the untreated control group. 3. FMH decreased the transcription of pro-inflammatory genes, whereas it increased transcription of anti-inflammatory genes, in HUVEC cells. Conclusion: FMH is effective as an antioxidant and for treatment and prevention of dyslipidemia, atherosclerosis, ischemic heart disease, stroke, and other cardiocerebrovascular diseases.
Abstract
Objectives: To investigate the effect of fermented extract of Artemisiae Iwayomogii Herba, Curcumae Longae, Crataegi Fructus, and Salviae Miltiorrhizae Radix (FMH) on anti-inflammation associated with dyslipidemia and anti-oxidation in RAW264.7 and HUVEC cells. Methods: The total polyphenols, total flavonoids, DPPH radical scavenging activity, ABTS radical scavenging activity, and cytotoxicity of FMH were measured. RAW264.7 cells treated with FMH were tested for production of NO, and for cytokine and LTB4 levels and HUVEC cells treated with FMH were examined for production of cDNA of genes related to inflammation. Results: 1. FMH contained polyphenols and flavonoids. The DPPH and ABTS radical scavenging activity of FMH increased in a concentration-dependent manner. 2. FMH treatment inhibited the production of nitric oxide (NO), cytokines, and LTB4 in RAW264.7 cell when compared to the untreated control group. 3. FMH decreased the transcription of pro-inflammatory genes, whereas it increased transcription of anti-inflammatory genes, in HUVEC cells. Conclusion: FMH is effective as an antioxidant and for treatment and prevention of dyslipidemia, atherosclerosis, ischemic heart disease, stroke, and other cardiocerebrovascular diseases.
참고문헌 (30)
- Statistics Korea, "2016 Death statistics" (2016)
- Korean Academy of Medical Sciences, "Guideline for Dyslipidemia in Primary Care" (2016), Guideline Information Center
- National Oriental Medical Department of Heart Internal Medicine, "Oriental neurocirculatory Internal Medicine, 3rd edition", pp.184~185 (2011), Gunja publishing company
- Cha BS, "Step to Internal Medicine Endocrinology, 4th edition", pp.389~ (2018), Jungdam publishing company
- Soon-Yeong Cho, "Sprague Dawley계 쥐에서의 홍게껍질의 항비만 및 항고지혈증 효능", Journal of Chitin and Chitosan, 15(3), pp.156~163 (2010), 한국키틴키토산학회
- 박소애, "加味地黃湯이 高脂血症 關聯 因子에 미치는 영향", 대한한방내과학회지, 30(2), pp.338~354 (2009), 대한한방내과학회
- Lee WC, "Nuroprotective Effect Yanggyuksanhwatang on Cerebral Infarction Induced by MCAO in Hyperlipidemic Rats", J Int Korean Med, 27(4), pp.915~926 (2006)
- 최성환, "생약재를 이용한 고지혈증 치료의 연구 동향 고찰", 대한한방내과학회지, 31(3), pp.448~456 (2010), 대한한방내과학회
- Han JM, "ACE Reduces Metabolic Abnormalities in a High-Fat Diet Mouse Model", eCAM, 2015(352647), pp.8~ (2015)
- Kim HT, "Effects of an Extract of Artemisiae Capillaris, Curcumae Longae, and Crataegi Fructus (IUS) on Antihyperlipidemia and Anti-oxidation in db", db Mouse Model, 2016, pp.37(3), 467~483
- 유주영, "茵蔯, 鬱金, 枳實 추출물(ACA)이 HepG2 세포에서 나타나는 이상지질혈증 관련 인자 발현 및 항산화에 미치는 영향", 대한한방내과학회지, 38(3), pp.367~375 (2017), 대한한방내과학회
- 차지윤, "HepG2 cell을 이용한 한인진, 울금, 나복자 복합물(ACR)의 이상지질혈증 관련 유전자 발현 억제 및 항산화 효능 평가", 대한한의학회지, 38(3), pp.43~58 (2017), 대한한의학회[DOI]
- 정은선, "HepG2 cell에서 한인진, 울금, 차전자 추출물(ACP)의 항산화 및 항이상지질혈증 효과", 동의생리병리학회지, 32(1), pp.13~23 (2018), 한의병리학회[DOI]
- Lee CS, "progress in oriental medicine clinical treatment of common diseases, 1st edition", pp.81~ (1991), China chinese medicine publishing company
- Textbook Compilation Committee of Oriental pathology, "Oriental pathology, 2nd edition", pp.94;113~ (2008), Oriental medicine cultural company
- 김형진, "LPS로 유발한 간손상 마우스에서 항산화 및 항염증 효능을 통한 천마와 증숙 발효 천마의 간보호 효과", Journal of Applied Biological Chemistry, 59(3), pp.179~188 (2016), 한국응용생명화학회
- 풍수김, "효소발효 백하수오의 고지혈증 흰쥐에 대한 지질대사 개선 효능 연구", 대한본초학회지, 30(6), pp.83~91 (2015), 대한본초학회
- 강대길, "솔잎 醱酵液이 白鼠의 高脂血證 미치는 영향", 동의생리병리학회지, 17(1), pp.139~144 (2003), 한의병리학회
- 최고은, "제2형 당뇨 마우스 모델에서 청혈플러스의 항고지혈 및 항산화효과", 동의생리병리학회지, 30(3), pp.164~176 (2016), 한의병리학회[DOI]
- World Health Organization, "Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2016" (2018)
- Committee for Guidelines for Management of Dyslipidemia, "2015 Korean Guidelines for Management of Dyslipidemia", J Lipid AtheroscJer, 4(1), pp.61~92 (2015)[DOI]
- Yang YG, "The translation of Hwangjenaegyung. 1st edition", pp.296~297;416 (1991), Iljoongsa
- Bang HJ, "The Oriental Medicine Review of Dyslipidemia", The journal of east-west medicines, 20(1), pp.25~36 (1995)
- 한효상, "발효 艾葉 추출물이 인간 간암세포주 HepG2 활성에 미치는 영향", 대한본초학회지, 28(3), pp.107~113 (2013), 대한본초학회
- Herbal medicine Compilation Committee of College of Oriental Medicine, "Herbal medicine. 2nd edition", pp.369;411~412;453;458 (2010), Younglimsa
- Go BS, "The encyclopedia of Chinese Herbal medicine, 2nd edition", pp.216;303~304;1604;2639 (1974), Shinmoonpung
- Hao G, "Increasing Oxidative Stress with Progressive Hyperlipidemia in Human: Relation between Malondialdehyde and Atherogenic Index", J Clin Biochem Nutr, 4(3), pp.154~158 (2008)
- Barber RD, "GAPD H as a housekeeping gene: analysis of GAPD H mRNA expression in a panel of 72 human tissues", Physiol Genomics, 21(3), pp.389~484 (2005)[DOI]
- Christopherson K. Hromas R, "Chemokine Regulation of Normal and Pathologic Immune Responses", Stem Cells, 19(5), pp.388~396 (2001)[DOI]
- Harrison's Internal Medicine Editorial Board of the Korean Society of Internal Medicine, "Harrison's Principles of Internal Medicine, 15th edition", pp.1420~ (2003)
